Huang Kuang
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Anti-PLA2R antibodies promote endothelial pyroptosis and a procoagulant phenotype through FcγRI signaling.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: May 13, 2026
Butyric Acid-Modified m-P14 Peptide Ameliorates Anti-Glomerular Basement Membrane Disease.
Journal: International journal of molecular sciences
Published: March 26, 2026
Elevated serum soluble α3(IV)NC1 correlates with kidney injury and worse outcome in patients with anti-glomerular basement membrane disease.
Journal: Frontiers in immunology
Published: October 19, 2025
Case Report: Anti-glomerular basement membrane disease during pregnancy with favorable renal outcome, sequential biopsies, and dual anti-α1/α3(IV) and anti-LM521 antibodies.
Journal: Frontiers in immunology
Published: September 28, 2025
Anti-glomerular basement membrane disease: variant forms and underlying mechanisms.
Journal: Kidney international
Published: September 12, 2025
The Hippo pathway: potential target for immunotherapy of crescentic glomerulonephritis.
Journal: Frontiers in immunology
Published: July 24, 2025
Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: May 08, 2025
Anti-PLA2R1 IgG-mediated podocyte PLA2R1 cleavage drives glomerular subepithelial immune complex deposition in membranous nephropathy.
Journal: Kidney international
Published: August 23, 2024
Epidemiology, clinical features, risk factors, and outcomes in anti-glomerular basement membrane disease: A systematic review and meta-analysis.
Journal: Autoimmunity reviews
Published: March 04, 2024
Last Updated: 09/26/2026